大剂量阿司匹林致川崎病患儿急性肝功能衰竭1例分析

doi:10.19803/j.1672-8629.2021.10.21

中国药物警戒 ›› 2021, Vol. 18 ›› Issue (10): 989-991.
DOI: 10.19803/j.1672-8629.2021.10.21

大剂量阿司匹林致川崎病患儿急性肝功能衰竭1例分析

喻明丽, 罗季, 陈永刚, 陈洁, 彭江丽^*

昆明市第三人民医院药剂科,云南昆明 650041

收稿日期:2020-01-20 出版日期:2021-10-15 发布日期:2021-10-27
通讯作者: ^*彭江丽,女,硕士,副主任药师,临床药学。E-mail：41660380@QQ.com
作者简介:喻明丽,女,硕士,主管药师,临床药学。

One Case of Acute Liver Failure in Children with Kawasaki Disease Induced by High-dose Aspirin

YU Mingli, LUO Ji, CHEN Yonggang, CHEN Jie, PENG Jiangli^*

Department of Pharmacy, the Third People's Hospital of Kunming, Kunming Yunnan 650041, China

Received:2020-01-20 Online:2021-10-15 Published:2021-10-27

摘要/Abstract

摘要： 目的提高临床使用大剂量阿司匹林的安全性。方法通过对 1 例川崎病患儿使用大剂量阿司匹林后出现严重肝衰竭的病例报道,结合国内外文献进行分析。结果本例患儿很可能是由阿斯匹林引起的肝损伤,阿司匹林引起药物肝损伤在临床中较为罕见,主要与使用剂量密切相关。结论对于川崎病患儿需要使用大剂量阿司匹林时,应密切监测患儿的肝功能及消化系统的反应,并应普及阿司匹林的血药浓度监测,以便预防阿司匹林引起严重肝损伤等药物不良反应。

关键词: 阿司匹林, 肝损伤, 药品不良反应

Abstract: Objective To improve the safety of clinical use of high-dose aspirin. Methods One case of severe liver failure in a child with Kawasaki disease after using high-dose aspirin was reported and analyzed in combination with domestic and foreign literature. Results The patient was likely to suffer from aspirin-induced liver injury, which is rare in clinical practice and mainly related to the dosage. Conclusion When children with Kawasaki disease need to use large doses of aspirin, the liver function and related digestive system reactions should be closely monitored. Blood concentration monitoring of aspirin should be popularized to prevent such adverse drug reactions such as severe liver injury.

Key words: aspirin, acute liver injury, adverse drug reaction

中图分类号:

R994.11

喻明丽, 罗季, 陈永刚, 陈洁, 彭江丽. 大剂量阿司匹林致川崎病患儿急性肝功能衰竭1例分析[J]. 中国药物警戒, 2021, 18(10): 989-991.

YU Mingli, LUO Ji, CHEN Yonggang, CHEN Jie, PENG Jiangli. One Case of Acute Liver Failure in Children with Kawasaki Disease Induced by High-dose Aspirin[J]. Chinese Journal of Pharmacovigilance, 2021, 18(10): 989-991.

参考文献

[1] Wang YP, Zhuang M.New advances in clinical application of aspirin[J]. Journal of Clinical Rational Drug Use(临床合理用药杂志), 2019, 12(2): 176-178.
[2] Laster J.Aspirin-induced acute liver injury[J]. ACG Case Reports Journal, 2014, 2(1): 48-49.
[3] Li LX.Analysis of adverse reactions caused by clinical application of aspirin[J]. Electronic Journal of Integrated Traditional Chinese and Western Medicine Cardiovascular Disease(中西医结合心血管病电子杂志), 2018, 6(33): 183.
[4] Hu LH, Wang XL.Medication consultation on application of aspirin in children with kawasaki disease and literature review[J].Journal of Pediatric Pharmacy(儿科药学杂志), 2018, 24(6): 37-39.
[5] Chen TC, Ng KF, Jeng LB, et al.Aspirin-related hepatotoxicity in a child after liver transplant[J]. Digestive Diseases and Sciences, 2001, 46(3): 486-488.
[6] Iancu T, Elian E.Letter: Aspirin-induced abnormalities of liver function[J]. American Journal of Diseases of Children, 1974, 128(1): 116-117.
[7] Yuan L, Zhang SZ, He GF, et al.Evaluation of immune hemolytic anemia induced by clozapine by Nord, s scale[J]. Central South Pharmacy(中南药学), 2017, 15(11): 1658-1661.
[8] Fu Y, Li XP, Yu ZY.et al.Assessment of the causality of severe diarrhea caused by paclitaxel in case reports by using Naranjo's assessment scale[J], Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2018, 38(20): 65-68.
[9] You Y.Application of Naranjo's assessment scale in assessment of rhabdomyolysis induced by paracetamol[J]. Evaluation and Analysis of Drug-Use in Hospitals of China(中国医院用药评价与分析), 2019, 19(2): 118-120.
[10] Ming YN.Research progress on the pathogenesis of drug-induced liver injury[J]. Practical Journal of Liver Diseases(实用肝脏病杂志), 2014, 17(6): 657-660.
[11] Liu HH, Liu ZW, Zhou X, et al.Mechanism and diagnosis of aspirin- induced liver injury[J]. Proceeding of Clinical Medicine(临床医药实践), 2018, 27(1): 60-63.
[12] Baumer JH, Love SJ, Gupta A, et al. Salicylate for the treatment of Kawasaki disease in children[J]. Cochrane Database Syst Rev, 2006(4): CD004175.
[13] Brian W, Mc C, Anne H, et al.diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the american heart association[J]. Circulation, 2017, 135(17): 927-999.
[14] Zhang QY, Jian PJ, Du JB, et al.Diagnosis, treatment and long - term management of kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and kawasaki disease, council on cardiovascular disease in the young, american heart association[J]. Journal of Applied Clinical Pediatrics(中华实用儿科临床杂志), 2012, 27(13): 1049-1056.
[15] Rowley AH.The complexities of the diagnosis and management of Kawasaki disease[J]. Infect Dis Clin North Am, 2015, 29(3): 525-537.
[16] Li Y, Jia LL, Hu BY, et al.Study on tablet splitting of 13 children hospitals and suggestion on establishing children-friendly drug specifications for common pediatric drugs[J].Chinese Journal of New Drugs(中国新药杂志), 2015, 24(23): 126-130.
[17] Lin Y.Accuracy study of tablets split dose and impact on children’s medication safety[D]. Shenyang: College of Pharmaceutical Sciences, Zhejiang University: Pharmacology, 2014.
[18] Committee of Experts on Rational of the Ministry of Health. Clinical medication guidelines for Chinese physicians and pharmacists(中国医师和药师用药指南)[M]. Chongqing: Chongqing Publishing House, 2014: 673-674.
[19] Cheng XP.Analysis of 177 cases of adverse drug reactions induced by BufIomedil[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2020, 17(1): 51-55.

大剂量阿司匹林致川崎病患儿急性肝功能衰竭1例分析

One Case of Acute Liver Failure in Children with Kawasaki Disease Induced by High-dose Aspirin

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	贾晋生, 刘红亮, 王青, 侯永芳, 李馨龄. 基于知识图谱联合ERNIE-DPCNN模型的药品不良反应自动关联性评价方法研究[J]. 中国药物警戒, 2024, 21(2): 163-166.
[2]	李应芬, 韩雷. 319例注射用脑蛋白水解物药品不良反应报告分析[J]. 中国药物警戒, 2024, 21(2): 195-198.
[3]	徐伟佳, 彭崎, 黄海渝, 张磊姣, 肖华, 吴雪. 285例新型抗肿瘤药物不良反应分析[J]. 中国药物警戒, 2024, 21(2): 199-203.
[4]	郭清华, 彭笑笑, 朱萍, 刘西霖, 杨颖华, 陈志海. 氨氯地平过量致多器官功能障碍综合征1例分析[J]. 中国药物警戒, 2024, 21(2): 204-207.
[5]	方美琳, 郑慧敏, 王存泽, 王凌, 阮君山. 注射用奥沙利铂致全身肌肉疼痛1例分析[J]. 中国药物警戒, 2024, 21(2): 208-210.
[6]	陈玉艳, 张明霞, 张涛, 张晋. 斯鲁利单抗注射液致间质性肺炎不良反应1例分析[J]. 中国药物警戒, 2024, 21(2): 213-215.
[7]	曹桂萍, 邓琳琳, 朱干红, 陆颖, 马爽, 陈玲玲, 刘丽丽. 天麻首乌片致严重肝损伤1例分析[J]. 中国药物警戒, 2024, 21(2): 216-218.
[8]	王欣, 史磊磊, 张雨涵, 谢允东, 刘继平. 多药耐药相关蛋白转运体在药物性肝损伤中的作用研究进展[J]. 中国药物警戒, 2024, 21(2): 229-234.
[9]	高云娟, 赵旭, 白天凯, 柏兆方, 王伽伯, 宋海波, 肖小河. 基于不良反应监测大数据的药品安全风险发现与识别策略[J]. 中国药物警戒, 2024, 21(1): 1-5.
[10]	郭龙鑫, 高云娟, 吴承钊, 龙敏娟, 祝胜凯, 宋海波, 赵旭, 肖小河. 基于不良反应监测大数据的中药药源性肝损伤风险信号新发现及易感因素初探[J]. 中国药物警戒, 2024, 21(1): 15-19.
[11]	高源, 石伟, 肖小河, 柏兆方, 王伽伯. 特异质型药物性肝损伤体内评价模型研究进展[J]. 中国药物警戒, 2024, 21(1): 33-39.
[12]	蒋文硕, 杨莉. 694例癫痫医师药师联合门诊患者药品不良反应分析[J]. 中国药物警戒, 2024, 21(1): 102-106.
[13]	陈华炎, 江东波, 郭春连, 杨家琪, 黎雨欣, 蔡伟明. 326例奈玛特韦片/利托那韦片治疗新型冠状病毒感染安全性分析[J]. 中国药物警戒, 2024, 21(1): 107-110.
[14]	詹姆斯·布坎南. 用 nR 改良海氏法则及 P_ALT 评估药物性肝损伤研究进展[J]. 中国药物警戒, 2024, 21(1): 117-120.
[15]	刘赛月, 吕小琴, 周耘. 疑似药品不良反应死亡病例调查及报告实施要点[J]. 中国药物警戒, 2023, 20(9): 971-974.